Summary
Definition
History and exam
Key diagnostic factors
- presence of risk factors
- anaesthesia or severe pain over site of infection
- fever
- palpitations, tachycardia, tachypnoea, hypotension, and lightheadedness
- nausea and vomiting
- delirium
- crepitus
- vesicles or bullae
- grey discoloration of skin
- oedema or induration
- location of lesion
Risk factors
- inpatient contact with index case
- Varicella zoster infection
- cutaneous injury, surgery, trauma
- non-traumatic skin lesions
- intravenous drug use
- chronic illness
- immunosuppression
- non-steroidal anti-inflammatory drugs (NSAIDs)
Diagnostic investigations
1st investigations to order
- surgical exploration
- blood and tissue cultures
- Gram stain
- full blood count and differential
- serum electrolytes
- serum urea and creatinine
- serum CRP
- serum creatine kinase
- liver function tests
- serum lactate
- clotting screen
- blood gas (venous or arterial)
Investigations to consider
- CT/MRI, x-ray, ultrasound
- fresh frozen section
Treatment algorithm
suspected necrotising fasciitis, organism unknown
type I necrotising fasciitis (polymicrobial)
type II necrotising fasciitis due to group A streptococcus
type II necrotising fasciitis due to Staphylococcus aureus
type II necrotising fasciitis due to Vibrio vulnificus
type II necrotising fasciitis due to Aeromonas hydrophila
type II necrotising fasciitis due to Clostridium
fungal infection
persistent cosmetic and functional defects after debridement
Contributors
Expert advisers
Melvyn Jenkins-Welch, BSc(Hons), MBBS, MSc, FRCA, FFICM
Consultant Critical Care Medicine
William Harvey Hospital
East Kent University Hospitals Foundation Trust
Ashford
UK
Disclosures
MJW declares that he has no competing interests.
Brian Angus, MD, FRCP
Professor
Oxford University
Infectious Diseases Consultant
John Radcliffe Hospital
Oxford
UK
Disclosures
BA declares that he has no competing interests.
Acknowledgements
BMJ Best Practice would like to gratefully acknowledge the previous expert contributors, whose work has been retained in parts of the content:
Kevin L. Steiner, MD, PhD, DTM&H
Fellow
Division of Infectious Diseases and International Health
University of Virginia
Charlottesville
VA
William A. Petri Jr, MD, PhD, FACP
Wade Hampton Frost Professor of Epidemiology
Professor of Medicine
Microbiology and Pathology
Division of Infectious Diseases and International Health
University of Virginia
Charlottesville
VA
John Abercrombie, FRCS
General and Colorectal Surgeon
Queen’s Medical Centre
Nottingham
UK
Disclosures: KLS and WAP declare that they have no competing interests. JA is a council member of the Royal College of Surgeons and provides expert advice to Spire Healthcare on clinical management of selected cases and on improving processes for review of cases resulting in mortality.
Peer reviewers
Kordo Saeed, MB, ChB, MSc, FRCPath, MD
Consultant Microbiologist
University Hospital Southampton NHS Foundation Trust
Honorary Senior Lecturer
University of Southampton
Southampton
UK
Disclosures
KS declares that he has no competing interests.
Editors
Annabel Sidwell
Section Editor and Comorbidities Editor, BMJ Best Practice
Disclosures
AS declares that she has no competing interests.
Tannaz Aliabadi-Oglesby
Lead Section Editor, BMJ Best Practice
Disclosures
TAO declares that she has no competing interests.
Adam Mitchell
Drug Editor, BMJ Best Practice
Disclosures
AM declares that he has no competing interests.
Differentials
- Cellulitis
- Impetigo
- Erysipelas
More DifferentialsGuidelines
- 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections
- Necrotising fasciitis
More GuidelinesLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer